Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9CGP

RyR1 disease mutant Y523S with FKBP12.6, nanodisc and inhibitor dantrolene in the absence of calcium with refined P1 domain

This is a non-PDB format compatible entry.
Summary for 9CGP
Entry DOI10.2210/pdb9cgp/pdb
Related7T64 7T65
EMDB information45584 45585 45947
DescriptorRyanodine receptor 1, Peptidyl-prolyl cis-trans isomerase FKBP1B, ZINC ION, ... (5 entities in total)
Functional Keywordsryanodine receptor, calcium channel, mutation, y523s, ryr1, dantrolene, membrane protein
Biological sourceOryctolagus cuniculus (rabbit)
More
Total number of polymer chains8
Total formula weight2313546.84
Authors
Iyer, K.A.,Samso, M. (deposition date: 2024-06-30, release date: 2024-12-11, Last modification date: 2025-02-19)
Primary citationIyer, K.A.,Kobayashi, T.,Murayama, T.,Samso, M.
Dantrolene inhibition of ryanodine receptor 1 carrying the severe malignant hyperthermia mutation Y522S visualized by cryo-EM.
Structure, 33:338-348.e4, 2025
Cited by
PubMed Abstract: Mutations in the skeletal isoform of the ryanodine receptor 1 (RyR1) pose grave risks during anesthesia or treatment with succinylcholine muscle relaxants. These can trigger a potentially lethal malignant hyperthermia (MH) episode via intracellular calcium increase mainly from RyR1 channel leakage. Dantrolene is the only known treatment option to prevent death. The main target of dantrolene is RyR1; however, little is known about the mechanism of inhibition. Cryoelectron microscopy (cryo-EM) structures of dantrolene bound to the severe MH Y522S RyR1 mutant in the closed and open states at 2.5-3.3 Å resolution revealed that the drug binds to the channel's cytoplasmic assembly, far from the ion gate, interacting with residues W882, W996, and R1000 in the P1 domain. The finding was validated by Ca imaging and [H]ryanodine binding in wild-type (WT) and alanine mutants. Dantrolene reduced channel opening probability by restricting the central activation module, "cooling down" the primed conformation caused by the mutation.
PubMed: 39708816
DOI: 10.1016/j.str.2024.11.018
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.34 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon